What is Castle Biosciences's price / earnings?

Castle Biosciences (CSTL) reported price / earnings of 40.9× in Q4 2024.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Castle Biosciences CSTL Price / earnings

Price / earnings at other companies

Labcorp HoldingsLH

22.9×-5.9×

VeracyteVCYT

29.1×-40.8×

Mesa LaboratoriesMLAB

116.1×—

Quest DiagnosticsDGX

22.1×+1.0×

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$724.58M+54.6%

Enterprise value$697.54M+64.6%

P/S2.1×+0.8×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Calculated from Castle Biosciences’s reported figures.

market cap/net income=40.9×

Based on the most recent quarter.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's price / earnings?: Castle Biosciences (CSTL) reported price / earnings of 40.9× in Q4 2024.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.